Administration of clopidogrel prior to PCI associated with reduction in major cardiac events
Among patients scheduled for a percutaneous coronary intervention (PCI; procedures such as balloon angioplasty or stent placement used to open narrowed coronary arteries), pretreatment with the antiplatelet agent clopidogrel ...
Cardiology
Dec 18, 2012 |
not rated yet |
0
|
ESC says don't forget to screen for diabetes in CAD patients
While it is well recognized that patients with diabetes are at risk of developing Coronary Artery Disease (CAD), on World Diabetes Day the European Society of Cardiology (ESC) highlights the fact that patients with CAD are ...
Diabetes
Nov 14, 2012 |
not rated yet |
0
Some heart patients may respond differently to anti-platelet drugs
The cause of heart attacks or strokes among some patients treated with anti-platelet drugs may be different than for patients who have undergone surgical procedures to restore blood flow, according to researchers at Duke ...
Cardiology
Nov 05, 2012 |
not rated yet |
0
|
Infusing 'good' cholesterol protein may lower risk of subsequent heart attack
An intravenous infusion of good cholesterol could reduce the risk of a subsequent heart attack, researchers reported at the American Heart Association's Scientific Sessions 2012.
Cardiology
Nov 05, 2012 |
3.3 / 5 (3) |
0
Heart attack packs a wallop to wallet of survivors, their employers
The economic impact of a heart attack and other forms of acute coronary syndrome goes beyond the hospital to the home and workplace, according to research presented at the American Heart Association's Scientific Sessions ...
Cardiology
Nov 05, 2012 |
not rated yet |
0
Study finds drug-eluting stents exhibit some benefits over bare-metal stents in patients over 80, though both demonstrat
Rarely tested in patients over the age of 80, a study found that drug-eluting stents exhibited some benefits over bare-metal stents, though both types of stents demonstrated a clinical benefit. Results of the XIMA trial were ...
Cardiology
Oct 26, 2012 |
not rated yet |
0
Researchers ID potential patient population who may benefit from novel anti-platelet treatment
Prasugrel, a novel anti-platelet therapy, is used to prevent recurrent cardiovascular events in patients who have had a prior heart attack, suffer severe chest pain and have been treated with coronary artery procedures (revascularization).
Cardiology
Oct 24, 2012 |
not rated yet |
0
Anergia prevalent in acute coronary syndrome patients
(HealthDay)—Anergia, or the lack of energy, is highly prevalent in patients with acute coronary syndromes (ACS), and correlates independently with several factors, including bodily pain and exercise participation, according ...
Cardiology
Oct 21, 2012 |
not rated yet |
0
Coronary angioplasty improves cardiac arrest survival
Coronary angioplasty improves survival in all patients with out of hospital cardiac arrest, according to research presented at the Acute Cardiac Care Congress 2012. The study was presented by Dr Annamaria Nicolino from the ...
Cardiology
Oct 20, 2012 |
5 / 5 (2) |
0
Nicotine replacement doesn't increase cardio risk after ACS
(HealthDay)—Use of nicotine replacement therapy (NRT) does not increase the risk of adverse cardiovascular events in the first year following acute coronary syndromes (ACS), according to research published ...
Cardiology
Sep 17, 2012 |
not rated yet |
0
Perceived control affects complication rates in patients with acute coronary syndrome
Patients admitted to hospital with obstructed heart arteries were three times more likely to experience complications when they were in hospital if they felt they were not in control of their condition, according to research ...
Cardiology
Sep 13, 2012 |
not rated yet |
0
New study clarifies benefits of coronary stents
(Medical Xpress)—Who should get stents, the tiny metal tubes designed to keep once-clogged coronary arteries open? Someone who is having a heart attack certainly should, and the life-prolonging benefits ...
Cardiology
Sep 12, 2012 |
not rated yet |
0
Global platelet reactivity and high risk ACS patients
Global platelet reactivity is more effective than responsiveness to clopidogrel in identifying acute coronary syndrome (ACS) patients at high risk of ischemic events, according to research presented at ESC Congress 2012.
Cardiology
Aug 28, 2012 |
not rated yet |
0
Personalized antiplatelet treatment improves outcome after PCI
Personalized antiplatelet treatment leads to better outcomes than standard antiplatelet treatment in patients undergoing coronary stent implantation, according to results from the MADONNA study presented at ESC Congress 2012.
Cardiology
Aug 28, 2012 |
not rated yet |
0
Rising cardiovascular incidence after Japanese earthquake 2011
The Japanese earthquake and tsunami of 11 March 2011, which hit the north-east coast of Japan with a magnitude of 9.0 on the Richter scale, was one of the largest ocean-trench earthquakes ever recorded in Japan. The tsunami ...
Cardiology
Aug 27, 2012 |
5 / 5 (2) |
0
